AXSM CEO executes option exercises; open‑market sales up to $134.49
Rhea-AI Filing Summary
Axsome Therapeutics (AXSM) disclosed insider transactions by its Chief Executive Officer, who is also a Director and 10% Owner. On November 3–5, 2025, the executive exercised stock options and sold the underlying shares pursuant to a pre‑approved Rule 10b5‑1 plan.
Exercises and related sales: on 11/03, 91,705 shares were acquired via option exercise at $8.02 and sold at a weighted average of $132.34 (range $124.16–$137.59). On 11/04, 50,459 shares were exercised at $8.02 and sold at a weighted average of $133.79 (range $131.50–$135.90). On 11/05, 21,775 shares were exercised at $8.02 and sold at a weighted average of $134.49 (range $131.60–$135.49). The filing notes the exercises were necessary due to approaching the options’ 10‑year expiration.
Following the reported transactions, the executive directly held 7,229 shares and indirectly held 7,344,500 shares through an entity over which he has voting and dispositive power.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 21,775 | $0.00 | -- |
| Exercise | Common Stock | 21,775 | $8.02 | $175K |
| Sale | Common Stock | 21,775 | $134.49 | $2.93M |
| Exercise | Stock Option (Right to Buy) | 50,459 | $0.00 | -- |
| Exercise | Common Stock | 50,459 | $8.02 | $405K |
| Sale | Common Stock | 50,459 | $133.79 | $6.75M |
| Exercise | Stock Option (Right to Buy) | 91,705 | $0.00 | -- |
| Exercise | Common Stock | 91,705 | $8.02 | $735K |
| Sale | Common Stock | 91,705 | $132.34 | $12.14M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Necessary exercise of stock options set to expire due to attainment of the 10-year expiration date of such options. Such transaction was pursuant to a pre-approved 10b5-1 plan. Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $124.16 and $137.59. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $131.50 and $135.90. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $131.60 and $135.49. Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
